Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
2.100
+0.250 (13.51%)
At close: Jun 27, 2025, 4:00 PM
2.110
+0.010 (0.48%)
After-hours: Jun 27, 2025, 4:33 PM EDT
Elutia Employees
Elutia had 51 employees as of December 31, 2024. The number of employees decreased by 3 or -5.56% compared to the previous year.
Employees
51
Change (1Y)
-3
Growth (1Y)
-5.56%
Revenue / Employee
$464,922
Profits / Employee
-$782,118
Market Cap
86.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | -3 | -5.56% |
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELUT News
- 2 days ago - Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewsWire
- 4 weeks ago - Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method - GlobeNewsWire
- 6 weeks ago - Elutia Inc. (ELUT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales - GlobeNewsWire
- 2 months ago - Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio - GlobeNewsWire
- 2 months ago - Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025 - GlobeNewsWire
- 2 months ago - Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29 - GlobeNewsWire
- 2 months ago - Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice - GlobeNewsWire